| Literature DB >> 1437377 |
Y Miaux1, F Lemarchand-Venencie, F Cyna-Gorse, J Frija, Y Cohen, L Dubertret, M Laval-Jeantet.
Abstract
Breast hemangioma in female infants is a rare benign lesion, prone to spontaneous regression. But when the lesion regresses there is a risk of breast atrophy if the breast bud is included in or very close to the hemangioma. A trial of corticosteroid therapy could be proposed to prevent this risk, but one must be sure that the breast bud is included in or very close to the hemangioma before treatment. We studied 4 children with breast hemangioma to evaluate the ability of MR Imaging in the diagnosis of breast bud inclusion. 0.5 Tesla axial Spin Echo T2-weighted images (TR = 2000 ms; TE = 120 ms) clearly depicted interface between high signal appearance of hemangioma and hypo-intensity of the breast bud: in our four patients we were able to determine whether or not the hemangioma involved the breast bud. Our preliminary study seems to demonstrate that MR imaging is a valuable imaging technique to determine which patients could be eligible for a trial of corticosteroid therapy.Entities:
Mesh:
Year: 1992 PMID: 1437377 DOI: 10.1007/bf02013514
Source DB: PubMed Journal: Pediatr Radiol ISSN: 0301-0449